Max Healthcare Institute Limited has informed the Exchange regarding Change in Auditors of the company.
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Max Healthcare's board approved audited financial results for FY25, with consolidated revenue from operations rising to ₹7,02,846 lakhs (up from ₹5,40,602 lakhs in FY24) and net profit at ₹1,07,588 lakhs versus ₹1,05,764 lakhs. A final dividend of ₹1.5 per share (15% of face value) was recommended. Statutory auditor Deloitte Haskins & Sells completed its 5-year term and will be replaced by S.R. Batliboi & Co. LLP for FY2025-26 to FY2029-30 — a routine rotation, not a midterm exit. The board also approved adding ~100 beds at Max Super Speciality Hospital, Nagpur, and disclosed the full acquisition of Jaypee Healthcare for ~₹625 crore. Operating cash flow was strong at ₹1,45,931 lakhs.
Routine auditor rotation and clean (unmodified) audit opinion are neutral to slightly positive. Strong revenue growth (~30% YoY), steady profit, and a ₹1.5 dividend reward shareholders, while the Nagpur expansion and Jaypee integration signal continued capacity-led growth.